Defining the cost of the Egyptian lymphatic filariasis elimination programme.

Reda M R Ramzy, Ann S Goldman, Hussein A Kamal
{"title":"Defining the cost of the Egyptian lymphatic filariasis elimination programme.","authors":"Reda M R Ramzy,&nbsp;Ann S Goldman,&nbsp;Hussein A Kamal","doi":"10.1186/1475-2883-4-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Lymphatic filariasis (LF) is targeted for global elimination. LF elimination programmes in different countries, including Egypt, are supported financially by national and international agencies. The national programme in Egypt is based on mass drug administration (MDA) of an annual dose of a combination of 2 drugs (DEC and albendazole) to all endemic villages. This study aimed primarily to estimate the Total and Government costs of two rounds of MDA conducted in Egypt in 2000 and 2001, the average cost per person treated, and the cost share of the different programme partners.</p><p><strong>Methods: </strong>The Total costs reflect the overall annual costs of the MDA programme, and we defined Government costs as those expenditures made by the Egyptian government to develop, implement and sustain the MDA programmes. We used a generic protocol developed in coordination with the Emory Lymphatic Filariasis Support Center. Our study was concerned with all costs to the government, donors and other implementing parties. Cost data were retrospectively gathered from local, regional and national Ministry of Health and Population records. The total estimates for each governorate were based on data from a representative district for the governorate; these were combined with national programme data for a national estimate.</p><p><strong>Results: </strong>The overall Total and Government costs for treating approximately 1,795,553 individuals living in all endemic villages in the year 2000 were USD 3,181,000 and USD 2,412,000, respectively. In 2001, the number of persons treated increased (29%) and the Total costs were USD 3,109,000 while Government costs were USD 2,331,000. In 2000, the average Total and Government costs per treated subject were USD 1.77 and USD 1.34, respectively, however, these costs decreased to USD 1.34 and USD 1.00, respectively in 2001. The coverage rate was 86.0% in 2000 and it increased to 88.0% in 2001.</p><p><strong>Conclusion: </strong>The Egyptian government provided 75.8% of all resources, as reflected in the Total cost estimates, and international agencies contributed the rest. Such data highlight both the commitment of the Egyptian government and the significance of the contributions of international bodies toward the LF elimination programme.</p>","PeriodicalId":84756,"journal":{"name":"Filaria journal","volume":"4 ","pages":"7"},"PeriodicalIF":0.0000,"publicationDate":"2005-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1475-2883-4-7","citationCount":"32","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Filaria journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/1475-2883-4-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 32

Abstract

Background: Lymphatic filariasis (LF) is targeted for global elimination. LF elimination programmes in different countries, including Egypt, are supported financially by national and international agencies. The national programme in Egypt is based on mass drug administration (MDA) of an annual dose of a combination of 2 drugs (DEC and albendazole) to all endemic villages. This study aimed primarily to estimate the Total and Government costs of two rounds of MDA conducted in Egypt in 2000 and 2001, the average cost per person treated, and the cost share of the different programme partners.

Methods: The Total costs reflect the overall annual costs of the MDA programme, and we defined Government costs as those expenditures made by the Egyptian government to develop, implement and sustain the MDA programmes. We used a generic protocol developed in coordination with the Emory Lymphatic Filariasis Support Center. Our study was concerned with all costs to the government, donors and other implementing parties. Cost data were retrospectively gathered from local, regional and national Ministry of Health and Population records. The total estimates for each governorate were based on data from a representative district for the governorate; these were combined with national programme data for a national estimate.

Results: The overall Total and Government costs for treating approximately 1,795,553 individuals living in all endemic villages in the year 2000 were USD 3,181,000 and USD 2,412,000, respectively. In 2001, the number of persons treated increased (29%) and the Total costs were USD 3,109,000 while Government costs were USD 2,331,000. In 2000, the average Total and Government costs per treated subject were USD 1.77 and USD 1.34, respectively, however, these costs decreased to USD 1.34 and USD 1.00, respectively in 2001. The coverage rate was 86.0% in 2000 and it increased to 88.0% in 2001.

Conclusion: The Egyptian government provided 75.8% of all resources, as reflected in the Total cost estimates, and international agencies contributed the rest. Such data highlight both the commitment of the Egyptian government and the significance of the contributions of international bodies toward the LF elimination programme.

Abstract Image

Abstract Image

Abstract Image

确定埃及消除淋巴丝虫病规划的费用。
背景:淋巴丝虫病(LF)是全球消灭的目标。包括埃及在内的不同国家的LF消除规划得到了国家和国际机构的财政支持。埃及国家规划的基础是向所有流行村庄每年大规模给药两种药物(DEC和阿苯达唑)的组合剂量。这项研究的主要目的是估计2000年和2001年在埃及进行的两轮大规模药物治疗的总费用和政府费用、人均治疗费用以及不同方案合作伙伴的费用分担。方法:总成本反映了MDA计划的总体年度成本,我们将政府成本定义为埃及政府为制定,实施和维持MDA计划所做的支出。我们使用了与埃默里淋巴丝虫病支持中心协调制定的通用方案。我们的研究关注的是政府、捐助者和其他实施方的所有成本。从地方、区域和国家卫生和人口部的记录中回顾性收集了成本数据。每个省的总估计数是根据该省一个代表性地区的数据计算的;这些数据与国家方案数据相结合,得出国家估计数。结果:2000年,在所有流行村庄治疗约1,795,553人的总费用和政府费用分别为3,181,000美元和2,412,000美元。2001年,接受治疗的人数增加了(29%),总费用为3,109,000美元,而政府费用为2,331,000美元。2000年,每名治疗对象的平均总费用和政府费用分别为1.77美元和1.34美元,但2001年这两项费用分别降至1.34美元和1.00美元。2000年的覆盖率为86.0%,2001年上升至88.0%。结论:埃及政府提供了全部资源的75.8%,反映在总成本估算中,其余部分由国际机构提供。这些数据既突出了埃及政府的承诺,也突出了国际机构对消灭LF方案的贡献的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信